Menu
/REGISTER
Montecito
Nixon Peabody
Premier Valley
Loading...
You are here:  Home  >  Biotech

Montecito Bank & Trust

Dignity Health
Latest

Amgen to team with Eli Lilly on COVID treatment

By   /  Friday, September 18th, 2020  /  Banking & Finance, Biotech, Central Coast Health Watch, East Ventura County, Latest news, Technology, Tri-County Economy, Tri-County Public Companies  /  No Comments

Thousand Oaks biotech giant Amgen announced another strategy to help address the coronavirus pandemic, entering into a manufacturing agreement with Eli Lilly to produce COVID-19 antibodies.  Eli Lilly, based in Indianapolis, has been pursuing several antibody treatments for the virus, the two companies said in a Sept. 17 news release. With access to Amgen’s manufacturing Read More →

Read More →
Latest

Making an ImmPACT: New firm raises $18M to pursue T-cell therapies

By   /  Friday, August 28th, 2020  /  Biotech, Latest news  /  No Comments

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen to join exclusive Dow Jones club

By   /  Monday, August 24th, 2020  /  Banking & Finance, Biotech, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  No Comments

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Amgen teams up with competitors in COVID treatment trial

By   /  Monday, August 3rd, 2020  /  Biotech, East Ventura County, Latest news, Tri-County Public Companies  /  Comments Off on Amgen teams up with competitors in COVID treatment trial

Amgen has joined two of its competitors in launching a trial for drugs to treat patients with COVID-19. Together with Chicago-based AbbVie and Japanese drugmaker Takeda Pharmaceutical, the Thousand Oaks biotech giant said Aug. 3 it had enrolled the first patients into a clinical trial for the anti-inflammatory drugs Otezla, cenicriviroc and Firazyr. Otezla is Read More →

Read More →
Latest

Amgen meets analyst estimates, but shares drop on Q2 earnings decline

By   /  Tuesday, July 28th, 2020  /  Banking & Finance, Biotech, Earnings, East Ventura County, Latest news, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Amgen meets analyst estimates, but shares drop on Q2 earnings decline

Amgen’s revenues climbed 6 percent in the second quarter, to $6.2 billion, despite the COVID-19 pandemic limiting hospital and physician operations and putting a hitch in diagnosis and treatment for many patients. Amgen’s earnings, announced July 28, met average analyst estimates. However, a 17 percent overall decline in net income for the Thousand Oaks biotech Read More →

Read More →
Latest

Amgen puts $421M into BeiGene

By   /  Monday, July 13th, 2020  /  Biotech, East Ventura County, Latest news, Technology, Tri-County Public Companies  /  Comments Off on Amgen puts $421M into BeiGene

Thousand Oaks biotech giant Amgen has upped its investment in Chinese oncology research firm BeiGene by $421 million. Amgen’s new investment, announced July 13, will allow the company maintain its ownership interest in BeiGene at 20.3 percent following a direct offering by the Chinese firm. Amgen shares rose more than 1 percent following the news Read More →

Read More →
Latest

Amgen’s growth over 40 years key to tri-county economy

By   /  Friday, July 3rd, 2020  /  Biotech, East Ventura County, left  /  Comments Off on Amgen’s growth over 40 years key to tri-county economy

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →